The Competing Financial Interests section in this Article is incorrect and should read:
“Dr. Karin Brüning is a member of the BMK consortium, able to produce sofosbuvir”.
Additional information
The online version of the original article can be found at 10.1038/srep40920
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Sacramento, C., de Melo, G., de Freitas, C. et al. Correction: Corrigendum: The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication. Sci Rep 7, 46772 (2017). https://doi.org/10.1038/srep46772
Published:
DOI: https://doi.org/10.1038/srep46772
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
